Buie MJ, Quan J, Windsor JW, Coward S, Hansen TM, King JA, Kotze PG, Gearry RB, Ng SC, Mak JW, Abreu MT. Global hospitalization trends for Crohn’s disease and ulcerative colitis in the 21st century: a systematic review with temporal analyses. Clin Gastroenterol Hepatol. 2023;21(9):2211–21. https://doi.org/10.1016/j.cgh.2022.06.030.

Article  PubMed  Google Scholar 

Wei SC, Sollano J, Hui YT, Yu W, Santos Estrella PV, Llamado LJ, Koram N. Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia. Expert Rev Gastroenterol Hepatol. 2021;15(3):275–89. https://doi.org/10.1080/17474124.2021.1840976.

Article  CAS  PubMed  Google Scholar 

Aniwan S, Santiago P, Loftus EV Jr, Park SH. The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United Eur Gastroenterol J. 2022;10(10):1063–76. https://doi.org/10.1002/ueg2.12350.

Article  CAS  Google Scholar 

Lewis JD, Parlett LE, Funk ML, Brensinger C, Pate V, Wu Q, Dawwas GK, Weiss A, Constant BD, McCauley M, Haynes K. Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States. Gastroenterology. 2023;165(5):1197–205. https://doi.org/10.1053/j.gastro.2023.07.003.

Article  CAS  PubMed  Google Scholar 

Weber F, Eger KI, March C, Croner RS, Meyer F. Manifestation of acute appendicitis as known but paradox visceral side effect of ulcerative colitis anti-inflammatory therapy with januskinase-inhibitor Tofacitinib (Xeljanz™). Pathol Res Pract. 2023;248: 154333. https://doi.org/10.1016/j.prp.2023.154333.

Article  CAS  PubMed  Google Scholar 

Gros B, Kaplan GG. Ulcerative colitis in adults: a review. JAMA. 2023;330(10):951–65. https://doi.org/10.1001/jama.2023.15389.

Article  CAS  PubMed  Google Scholar 

Sandborn WJ, Danese S, Leszczyszyn J, Romatowski J, Altintas E, Peeva E, Hassan-Zahraee M, Vincent MS, Reddy PS, Banfield C, Salganik M. Oral ritlecitinib and brepocitinib for moderate-to-severe ulcerative colitis: results from a randomized, phase 2b study. Clin Gastroenterol Hepatol. 2023. https://doi.org/10.1016/j.cgh.2022.12.029.

Article  PubMed  Google Scholar 

Lim J, Rezaie A. Irritable bowel syndrome-like symptoms in quiescent inflammatory bowel disease: a practical approach to diagnosis and treatment of organic causes. Dig Dis Sci. 2023;68(11):4081–97. https://doi.org/10.1007/s10620-023-08095-w.

Article  PubMed  PubMed Central  Google Scholar 

Singh S, Dulai PS. Ulcerative colitis: clinical manifestations and management. Yamada's Textbook of Gastroenterology. 2022:1248–93.https://doi.org/10.1002/9781118512104.ch28

Kotze PG, Heuthorst L, Lightner AL, Damião AO, Bemelman WA. New insights on the surgical management of ulcerative colitis in the 21st century. Lancet Gastroenterol Hepatol. 2022. https://doi.org/10.1016/S2468-1253(22)00001-2.

Article  PubMed  PubMed Central  Google Scholar 

Raine T, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V, Bachmann O, Bettenworth D, Chaparro M, Czuber-Dochan W, Eder P. ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohns Colitis. 2022;16(1):2–17. https://doi.org/10.1093/ecco-jcc/jjab178.

Article  PubMed  Google Scholar 

Guo XY, Liu XJ, Hao JY. Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment. J Dig Dis. 2020;21(3):147–59. https://doi.org/10.1111/1751-2980.12849.

Article  PubMed  Google Scholar 

Amiot A, Bouguen G, Bonnaud G, Bouhnik Y, Hagege H, Peyrin-Biroulet L, Abitbol V, Malamut G, Amiot A, Boruchowicz A, Siproudhis L. Clinical guidelines for the management of inflammatory bowel disease: update of a French national consensus. Dig Liver Dis. 2021;53(1):35–43. https://doi.org/10.1016/j.dld.2020.10.018.

Article  CAS  PubMed  Google Scholar 

Liu S, Eisenstein S. State-of-the-art surgery for ulcerative colitis. Langenbeck’s Arch Surg. 2021;406(6):1751–61. https://doi.org/10.1007/s00423-021-02295-6.

Article  Google Scholar 

Lu L, Dong J, Liu Y, Qian Y, Zhang G, Zhou W, Zhao A, Ji G, Xu H. New insights into natural products that target the gut microbiota: effects on the prevention and treatment of colorectal cancer. Front Pharmacol. 2022;13: 964793. https://doi.org/10.3389/fphar.2022.964793.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salibay CC, Mahboob T, Verma AK, San Sebastian JS, Tabo HA, Raju CS, Nissapatorn V. Natural product–derived drugs for the treatment of inflammatory bowel diseases (IBD). Inflamm Nat Prod. 2021. https://doi.org/10.5217/ir.2014.12.2.103.

Article  Google Scholar 

Xue JC, Yuan S, Meng H, Hou XT, Li J, Zhang HM, Chen LL, Zhang CH, Zhang QG. The role and mechanism of flavonoid herbal natural products in ulcerative colitis. Biomed Pharmacother. 2023;158: 114086. https://doi.org/10.1016/j.biopha.2022.114086.

Article  CAS  PubMed  Google Scholar 

Duan L, Cheng S, Li L, Liu Y, Wang D, Liu G. Natural anti-inflammatory compounds as drug candidates for inflammatory bowel disease. Front Pharmacol. 2021;14(12): 684486. https://doi.org/10.3389/fphar.2021.684486.

Article  CAS  Google Scholar 

Akkol EK, Karpuz B, Sobarzo-Sánchez E, Khan H. A phytopharmacological overview of medicinal plants used for prophylactic and treatment of colitis. Food Chem Toxicol. 2020;144: 111628. https://doi.org/10.1016/j.fct.2020.111628.

Article  CAS  PubMed  Google Scholar 

Dunleavy KA, Raffals LE, Camilleri M. Intestinal barrier dysfunction in inflammatory bowel disease: underpinning pathogenesis and therapeutics. Digest Dis Sci. 2023;68(12):4306–20. https://doi.org/10.1007/s10620-023-08122-w.

Article  PubMed  Google Scholar 

Liu Z, Zhang Y, Jin T, Yi C, Ocansey DK, Mao F. The role of NOD2 in intestinal immune response and microbiota modulation: a therapeutic target in inflammatory bowel disease. Int Immunopharmacol. 2022;113: 109466. https://doi.org/10.1016/j.intimp.2022.109466.

Article  CAS  PubMed  Google Scholar 

Fu Q, Song T, Ma X, Cui J. Research progress on the relationship between intestinal microecology and intestinal bowel disease. Anim Models Exp Med. 2022;5(4):297–310. https://doi.org/10.1002/ame2.12262.

Article  CAS  Google Scholar 

Chu J, Feng S, Guo C, Xue B, He K, Li L. Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: s review. Biomed Pharmacother. 2023;164: 114985. https://doi.org/10.1016/j.biopha.2023.114985.

Article  CAS  PubMed  Google Scholar 

Mahapatro M, Erkert L, Becker C. Cytokine-mediated crosstalk between immune cells and epithelial cells in the gut. Cells. 2021;10(1):111. https://doi.org/10.3390/cells10010111.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakase H, Sato N, Mizuno N, Ikawa Y. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmunity Rev. 2022;21(3): 103017. https://doi.org/10.1016/j.autrev.2021.103017.

Article  CAS  Google Scholar 

Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin. 2020;49(4):643–54. https://doi.org/10.1016/j.gtc.2020.07.005.

Article  Google Scholar 

Kaur A, Goggolidou P. Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies. J Inflamm. 2020;17:1–8. https://doi.org/10.1186/s12950-020-00246-4.

Article  Google Scholar 

Kałużna A, Olczyk P, Komosińska-Vassev K. The role of innate and adaptive immune cells in the pathogenesis and development of the inflammatory response in ulcerative colitis. J Clin Med. 2022;11(2):400. https://doi.org/10.3390/jcm11020400.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gomez-Bris R, Saez A, Herrero-Fernandez B, Rius C, Sanchez-Martinez H, Gonzalez-Granado JM. CD4 T-cell subsets and the pathophysiology of inflammatory bowel disease. Int J Mol Sci. 2023;24(3):2696. https://doi.org/10.3390/ijms24032696.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tindemans I, Joosse ME, Samsom JN. Dissecting the heterogeneity in T-cell mediated inflammation in IBD. Cells. 2020;9(1):110. https://doi.org/10.3390/cells9010110.

Article